The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Chemotherapy (CT) with or without carboplatin as neoadjuvant treatment in patients with basal-like breast cancer: GEICAM 2006-03-A multicenter, randomized phase II study.
E. Alba
No relevant relationships to disclose
J. I. Chacon
No relevant relationships to disclose
A. Lluch
No relevant relationships to disclose
L. GarcĂ­a-Estevez
No relevant relationships to disclose
A. Anton
No relevant relationships to disclose
B. Cirauqui
No relevant relationships to disclose
J. A. Lopez Garcia-Asenjo
No relevant relationships to disclose
E. M. Carrasco
No relevant relationships to disclose
C. Rodriguez
No relevant relationships to disclose
M. J. Escudero
No relevant relationships to disclose
A. Sanchez
No relevant relationships to disclose
N. Ribelles
No relevant relationships to disclose
C. Romero
No relevant relationships to disclose
J. Alvarez
No relevant relationships to disclose
J. Albanell
No relevant relationships to disclose